{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:54:28Z","timestamp":1792616068546,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"crossref","award":["1084046"],"award-info":[{"award-number":["1084046"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3555-5","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T09:03:03Z","timestamp":1564995783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan"],"prefix":"10.1186","volume":"20","author":[{"given":"Serigne N.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Haydu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette L.","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine J.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan H.","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-578X","authenticated-orcid":false,"given":"Gerald B.","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"3555_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/1756-0500-7-412","volume":"7","author":"GB Fogarty","year":"2014","unstructured":"Fogarty GB, Hong A, Dolven Jacobsen K, Reisse CH, Shivalingam B, Burmeister B, et al. Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. BMC Res Notes. 2014;7:412.","journal-title":"BMC Res Notes"},{"key":"3555_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2407-11-142","volume":"11","author":"G Fogarty","year":"2011","unstructured":"Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Forder PM, et al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients\u2014a randomised phase III trial. BMC Cancer. 2011;11:142.","journal-title":"BMC Cancer"},{"key":"3555_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13104-015-1153-5","volume":"8","author":"GB Fogarty","year":"2015","unstructured":"Fogarty GB, Hong A, Dolven-Jacobsen K, Reisse CH, Burmeister B, Haydu LH, et al. First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality. BMC Res Notes. 2015;8:192.","journal-title":"BMC Res Notes"},{"issue":"34","key":"3555_CR4","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","volume":"32","author":"V Gondi","year":"2014","unstructured":"Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trials. J Clin Oncol. 2014;32(34):3810\u20136.","journal-title":"J Clin Oncol"},{"key":"3555_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","volume":"12","author":"R Brandt","year":"1998","unstructured":"Brandt R, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test\u2013Revised: normative data and analyses of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43\u201355.","journal-title":"Clin Neuropsychol"},{"key":"3555_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/1385404049052420","volume":"18","author":"AJ Levine","year":"2004","unstructured":"Levine AJ, Miller EN, Becker JT, Selnes OA, Cohen BA. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol. 2004;18:373\u201384.","journal-title":"Clin Neuropsychol"},{"key":"3555_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/arclin\/11.4.329","volume":"11","author":"RM Ruff","year":"1996","unstructured":"Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11:329\u201338.","journal-title":"Arch Clin Neuropsychol"},{"issue":"4","key":"3555_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","volume":"50","author":"M Groenvold","year":"1997","unstructured":"Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50(4):441\u201350.","journal-title":"J Clin Epidemiol"},{"issue":"15_suppl","key":"3555_CR9","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1200\/jco.2008.26.15_suppl.2041","volume":"26","author":"MJ Taphoorn","year":"2008","unstructured":"Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff R, Van den Bent MJ, Bottomley A. The EORTC QLQ-BN20 questionnaire for assessing the health-related quality of life (HRQoL) in brain cancer patients: a phase IV validation on behalf of the EORTC QLG, BCG, ROG, NCIC-CTG. J Clin Oncology. 2008;26(15_suppl):2041.","journal-title":"J Clin Oncology"},{"issue":"10","key":"3555_CR10","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"key":"3555_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13854040490501448","volume":"18","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Rippeth JD, et al. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol. 2004;18:234\u201348.","journal-title":"Clin Neuropsychol"},{"key":"3555_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26:307\u201319.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"11","key":"3555_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"Chang","year":"2009","unstructured":"Chang, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncology. 2009;10(11):1037\u201344.","journal-title":"Lancet Oncology"},{"issue":"3","key":"3555_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1470-2045(09)70389-4","volume":"11","author":"U Mahmood","year":"2010","unstructured":"Mahmood U, et al. Whole-brain irradiation for patients with brain metastases: still the standard of care. Lancet Oncol. 2010;11(3):221\u20132 author reply 223.","journal-title":"Lancet Oncol"},{"key":"3555_CR15","volume-title":"Group sequential methods with applications to clinical trials","author":"C Jennison","year":"2000","unstructured":"Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Washington, DC: Chapman & Hall\/CRC; 2000."},{"key":"3555_CR16","volume-title":"Competing risks: a practical perspective","author":"M Pintilie","year":"2007","unstructured":"Pintilie M. Competing risks: a practical perspective. Chichester: John Wiley & Sons; 2007."},{"key":"3555_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141\u201354.","journal-title":"Ann Stat"},{"issue":"3","key":"3555_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40258-013-0035-z","volume":"11","author":"R Norman","year":"2013","unstructured":"Norman R, Cronin P, Viney R. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl Health Econ Health Policy. 2013;11(3):287\u201398.","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"3555_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1524-4733.2008.00405.x","volume":"12","author":"L McKenzie","year":"2009","unstructured":"McKenzie L, van der Pol M. Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data. Value Health. 2009;12(1):167\u201371.","journal-title":"Value Health"},{"issue":"17","key":"3555_CR20","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1080\/00949655.2018.1520854","volume":"88","author":"N Nooraee","year":"2018","unstructured":"Nooraee N, Molenberghs G, Ormel J, Van den Heuvel ER. Strategies for handling missing data in longitudinal studies with questionnaires. J Stat Comput Simul. 2018;88(17):3415\u201336.","journal-title":"J Stat Comput Simul"},{"key":"3555_CR21","volume-title":"ICH Harmonised Tripartite Guideline: structure and content of clinical study reports E3","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Expert Working Group","year":"1995","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Expert Working Group. ICH Harmonised Tripartite Guideline: structure and content of clinical study reports E3. Geneva: ICH; 1995."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3555-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T19:19:47Z","timestamp":1596482387000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3555-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3555"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3555-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol has been approved by Cancer Institute NSW Clinical Research Ethics Committee (Reference 2007C\/11\/032) on 1 April 2009. The project was transferred to the Sydney Local Health District Ethics Review Committee (RPAH Zone), and ethical approval was granted on 5 February 2014 (References X13-0329 and HREC\/13\/RPAH\/465). The study was carried out in compliance with national and state legal and regulatory requirements and according to the International Principles of Good Clinical Practice (ICH-GCP). As such all trial participants gave informed consent prior to joining the trial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}